Low Testosterone, Inflammation and the Ketogenic Diet

Low testosterone isn’t merely a matter of libido or gym performance. Medical researchers now view it as part of a broader syndrome called male obesity secondary hypogonadism (MOSH). In this condition, excess visceral fat, metabolic syndrome and chronic inflammation diminish circulating testosterone and increase estrogen levels. A study of men with high levels of obesity found that body‑mass index correlated positively with inflammation markers (high‑sensitivity C‑reactive protein, insulin resistance, and leptin levels) and negatively with testosterone levels. This research underscores that low testosterone is entwined with inflammation, cardiovascular risk and metabolic health rather than being a standalone problem.

Adipose Tissue, Aromatase and the Estrogen Loop

White fat tissue behaves like an endocrine organ. It expresses aromatase, an enzyme that converts testosterone into estrogen. In obesity, aromatase activity and leptin secretion increase; this raises estrogen levels and suppresses luteinising hormone (LH) pulses. Elevated leptin directly inhibits Spermogenesis, while higher estrogen promotes additional fat deposition, creating a feedback loop where fat accumulation leads to lower testosterone, and low testosterone promotes further fat gain. This “vicious cycle” explains why men with more fat around the mid section often develop metabolic hypogonadism and why reducing inflammation and fat mass is crucial to restoring hormonal balance.

Insights from Obesity‑Treatment Studies

Research in bariatric‑surgery cohorts provides insight into how inflammation and hormones interact. In a study of 24 men undergoing bariatric surgery, higher BMI correlates with higher inflammation, and lower testosterone associated with increased insulin resistance, as measured by fasting insulin and HBA1C. In vitro experiments showed that exposing human fat cells to physiological doses of testosterone reduced expression of pro-inflammatory messengers. Together, these findings suggest that healthy testosterone levels directly regulate fat metabolism and inflammatory signaling, while inflammation and adipose tissue derived cytokines suppress testicular steroidogenesis and sperm quality and production.

Ketogenic diets dramatically reduce carbohydrates (<30 g/day), pushing the body to use fat as its primary fuel and produce ketone bodies. Low‑carb, high‑fat ketogenic diets have attracted attention for their potential to lower inflammation, support weight loss and improve cardiovascular markers. A UC San Francisco study found that ketogenic diets significantly altered the gut microbiome, reducing Bifidobacteria and shifting major phyla (Actinobacteria, Bacteroidetes and Firmicutes). Additional experiments in mice showed that ketone bodies themselves directly affect the microbiome and reduce Th17 immune cells. These T helper cells that are essential for fighting infections but also drive inflammation in autoimmune diseases. These microbial shifts suggest that ketogenic diets may suppress inflammation via changes in gut ecosystems.

Recent preclinical work goes a step further, showing that ketone bodies can induce beneficial metabolites in the gut. Researchers observed that mice on a ketogenic diet had higher levels of β‑hydroxybutyrate , a ketone body that the gut converts into energy and signaling molecules. βHB prompted the bacterium Lactobacillus murinus to produce indole lactic acid (ILA) , which blocked activation of T helper 17 cells. In a mouse model of multiple sclerosis, supplementing a high‑fat diet with βHB or ILA reduced disease severity. The study notes that ketogenic diets severely restrict carbohydrate‑rich foods and rely on fat for fuel; this metabolic shift leads to ketone production, microbiome changes and dampened inflammatory responses. While it remains to be tested in humans, these findings offer hope that targeted supplements could replicate the anti‑inflammatory benefits of ketosis without long‑term dietary restriction.

Ketogenic approaches may also influence testosterone. In a single‑arm study of 20 overweight or obese men with metabolic hypogonadism, a very‑low‑calorie ketogenic diet reduced body weight and insulin markers and led to a mean 218 % increase in total testosterone levels over twelve weeks. At baseline, the participants exhibited elevated insulin, and many had testosterone values within the hypogonadal range. After the diet, none remained hypogonadal and most metabolic markers normalized. Although controlled trials are still needed, this evidence suggests that ketosis can break the cycle of obesity, inflammation and low testosterone by reducing visceral fat and improving insulin sensitivity.

Finally, low testosterone and chronic inflammation feed into each other; visceral fat increases aromatase and pro‑inflammatory cytokines, which suppress the hypothalamic‑pituitary gonadal axis and reduce testosterone. Ketogenic diets might offer a multifaceted intervention by promoting fat loss, producing anti‑inflammatory ketone bodies and reshaping the microbiome, they address multiple drivers of hypogonadism and metabolic dysfunction. While lifestyle interventions like whole‑food diets, exercise and sleep hygiene remain foundational, the emerging science around ketogenic diets and targeted ketone supplementation offers a promising avenue for men struggling with low testosterone linked with inflammation.